Pfizer
Ruth Ann Lepasana has extensive experience in regulatory operations and compliance within the pharmaceutical and healthcare sectors. Currently serving as a Pfizer Business Partner in Promotional Review within MLR Operations at Indegene since March 2021, Ruth Ann has previously held significant positions including Senior Content Manager for the MLR Team at TBWA\WORLDHEALTH and various roles at Area 23, including Regulatory Operations Supervisor and Manager. Additional experience encompasses a Senior Regulatory Associate position at Saatchi & Saatchi Wellness and U.S. REMS Quality Operations Coordinator at Celgene. Ruth Ann began the career as a Pharmacist Technician at Midland Pharmacy. Educational credentials include a Bachelor of Arts in Political Science from Kean University and a Master of Science in Jurisprudence specializing in Pharma/Medical Device Law & Compliance from Seton Hall University School of Law.
This person is not in the org chart
This person is not in any teams
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.